Effects of Methylphenidate on Cognitive Function and Gait in Patients With Parkinson's Disease
Authors:
- Jeffrey M. HausdorffJHJeffrey M. Hausdorff
- Talia HermanTHTalia Herman
- Ely S. SimonESEly S. Simon
- Nir GiladiNGNir Giladi
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 29 (1) , 15-17
Abstract
Twenty-one patients with Parkinson's disease were studied before and 2 h after the administration of a single dose of 20 mg of methylphenidate. In response to methylphenidate, attention significantly improved, whereas memory and visual-spatial performance were unchanged. Gait speed, stride time variability, and Timed Up and Go times (demonstrated measures of fall risk) significantly improved. These findings suggest a new potential pharmacologic means of enhancing mobility and decreasing fall risk in Parkinson's disease.Keywords
This publication has 9 references indexed in Scilit:
- Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding?European Journal of Neuroscience, 2005
- Walking is more like catching than tapping: gait in the elderly as a complex cognitive taskExperimental Brain Research, 2005
- The dopamine transporter: Importance in Parkinson's diseaseAnnals of Neurology, 2004
- Validity of a novel computerized cognitive battery for mild cognitive impairmentBMC Geriatrics, 2003
- Gait variability and fall risk in community-living older adults: A 1-year prospective studyArchives of Physical Medicine and Rehabilitation, 2001
- Methylphenidate Increases the Motor Effects of L-Dopa in Parkinson's Disease: A Pilot StudyClinical Neuropharmacology, 2001
- Guideline for the Prevention of Falls in Older PersonsJournal of the American Geriatrics Society, 2001
- Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral MethylphenidateAmerican Journal of Psychiatry, 1998
- Stride length regulation in Parkinson's diseaseBrain, 1996